Your browser doesn't support javascript.
loading
DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays.
Singh, Amrit; Shannon, Casey P; Gautier, Benoît; Rohart, Florian; Vacher, Michaël; Tebbutt, Scott J; Lê Cao, Kim-Anh.
Afiliação
  • Singh A; Prevention of Organ Failure (PROOF) Centre of Excellence, University of British Columbia, Vancouver, BC, Canada.
  • Shannon CP; Prevention of Organ Failure (PROOF) Centre of Excellence, University of British Columbia, Vancouver, BC, Canada.
  • Gautier B; The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia.
  • Rohart F; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.
  • Vacher M; Australian eHealth Research Centre, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Queensland, Australia.
  • Tebbutt SJ; Prevention of Organ Failure (PROOF) Centre of Excellence, University of British Columbia, Vancouver, BC, Canada.
  • Lê Cao KA; Melbourne Integrative Genomics, School of Mathematics and Statistics, The University of Melbourne, Melbourne, Australia.
Bioinformatics ; 35(17): 3055-3062, 2019 09 01.
Article em En | MEDLINE | ID: mdl-30657866
ABSTRACT
MOTIVATION In the continuously expanding omics era, novel computational and statistical strategies are needed for data integration and identification of biomarkers and molecular signatures. We present Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO), a multi-omics integrative method that seeks for common information across different data types through the selection of a subset of molecular features, while discriminating between multiple phenotypic groups.

RESULTS:

Using simulations and benchmark multi-omics studies, we show that DIABLO identifies features with superior biological relevance compared with existing unsupervised integrative methods, while achieving predictive performance comparable to state-of-the-art supervised approaches. DIABLO is versatile, allowing for modular-based analyses and cross-over study designs. In two case studies, DIABLO identified both known and novel multi-omics biomarkers consisting of mRNAs, miRNAs, CpGs, proteins and metabolites. AVAILABILITY AND IMPLEMENTATION DIABLO is implemented in the mixOmics R Bioconductor package with functions for parameters' choice and visualization to assist in the interpretation of the integrative analyses, along with tutorials on http//mixomics.org and in our Bioconductor vignette. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Software Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Software Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article